Bharat Biotech in-licences GSK’s Shigella vaccine candidate
India Business News: Bharat Biotech has in-licensed GSK’s Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-
Source
<meta name="google-adsense-account" content="ca-pub-6363428395369086">
- Tata AIA Life Insurance announces all-time high bonus of ₹1,842
- Futures & Options: jackpots or ticking time bombs?